Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Bortezomib × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 49 Neoplasms, Plasma Cell 5 Immunoglobulin Light-chain Amyloidosis 5 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Paraproteinemias 3 Waldenstrom Macroglobulinemia 2 Renal Insufficiency 2 Neoplasms 2 Lymphoproliferative Disorders 2 Leukemia, Myeloid, Acute 2 Burkitt Lymphoma 2 Amyloidosis 2 beta-Thalassemia 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphadenopathy 1 Immunoproliferative Disorders 1 Hematologic Neoplasms 1 HIV Infections 1 Breast Neoplasms 1 Anemia, Sickle Cell 1

Interventions

Rituximab 19 Cyclophosphamide 13 Lenalidomide 10 zanubrutinib 8 fludarabine 8 venetoclax 5 fludarabine phosphate 5 pirtobrutinib 4 orelabrutinib 4 Vincristine 4 obinutuzumab 3 Whole-Body Irradiation 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 CT-P10 3 ibrutinib 2 Therapeutics 2 Radiation 2 Mycophenolic Acid 2 Maintenance 2 Leukapheresis 2 Immunotherapy, Adoptive 2 Granulocyte Colony-Stimulating Factor 2 Cyclosporine 2 Biopsy 2 Bendamustine Hydrochloride 2 voruciclib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡